Venture Partner at Newton Biocapital
Check size: Newton Biocapital does not publish a standard current check-size range on its official site.
Daisuke Morishita invests or supports investments through Newton Biocapital's published strategy: Invest in private life-sciences companies in Europe and Japan whose products address important unmet medical needs.
Present the unmet need, evidence, intellectual property, regulatory and clinical plan, team and Europe-Japan opportunity.
Strong science, experienced teams and differentiated healthcare products with credible development and internationalization paths.
Opportunities outside life sciences or without evidence of unmet need, differentiation and development feasibility are less aligned.